Cannabis News
Market-moving headlines, earnings, and regulatory shifts across the cannabis sector
Track the developments that move cannabis stocks — from quarterly earnings and M&A deals to state-level legalization votes and federal policy changes. Articles are tagged with relevant stock tickers so you can see which companies are affected and jump straight to their market data.
White House Backs Hemp CBD Legality as November Ban Looms
Trump administration urges Congress to prevent federal recriminalization of hemp-derived CBD products, creating regulatory uncertainty for industry players.
Trulieve Scores NYSE Uplisting as Cannabis Stocks Eye Mainstream Appeal
Florida's largest MSO joins major exchange, signaling institutional acceptance despite federal headwinds facing cannabis sector.
Ayurcann Holdings Trades Near Zero as Cannabis Stock Hits Rock Bottom
AYURF shares trade at effectively zero dollars, highlighting severe distress in the micro-cap cannabis sector amid ongoing industry challenges.
TPCO Holding Plunges 13% on Heavy Volume Amid Ongoing Struggles
The Parent Company's shares fell to $0.16 as investors continued to pressure the cannabis operator facing financial headwinds.
PharmaCielo Crashes 26.4% as CBD Company Hits New Lows
PharmaCielo plunged 26.4% to $0.04 on elevated volume, highlighting ongoing struggles in the CBD sector amid challenging market conditions.
Greater Cannabis Company Crashes 36% as Penny Stock Faces Crisis
GCAN plunged to $0.12 amid heightened volatility, trading 97% below its 52-week high of $3.60 as the micro-cap MSO struggles.
WNBA Drops Cannabis Ban, Opens Door for Player Endorsement Deals
Professional women's basketball league removes marijuana from prohibited substances list while establishing framework for athlete sponsorship agreements.
WNBA Removes Cannabis From Banned Substances, Opens Endorsement Door
Professional basketball league becomes latest major sports organization to embrace cannabis normalization, creating new marketing opportunities for industry brands.
Cannabis Investors Eye Berkshire's Concentration Strategy Amid Sector Volatility
Berkshire's shift to five-stock focus highlights portfolio concentration benefits as cannabis investors weigh diversification vs. conviction plays.
FDA Grants Breakthrough Status to Cannabis Pain Treatment
Vertanical's VER-01 receives critical FDA designation, potentially becoming first approved cannabis-derived pain medication
Cannara Biotech Tumbles 5.1% as Cannabis Stock Faces Pressure
LOVFF shares dropped to $1.30 amid light trading volume, trading closer to annual lows as the Quebec-based cultivator navigates market challenges.
ASX Cannabis Stocks Eye Recovery as Market Conditions Shift
Australian cannabis equities show signs of stabilization after prolonged downturn, with investors monitoring regulatory developments and operational improvements.
ASX Cannabis Stocks See Fresh Investor Interest Amid Market Shift
Australian cannabis equities attract renewed attention as institutional investors reassess sector fundamentals following regulatory developments.
ASX Cannabis Stocks Gain Momentum as Sector Dynamics Evolve
Australian cannabis equities attract renewed investor attention amid shifting regulatory landscape and evolving market fundamentals across the sector.
Nigeria Advances Medical Cannabis Legalization Framework
Africa's largest economy takes regulatory steps toward medical marijuana approval, potentially opening massive new market for global cannabis operators.
AI Tech Disruption Reshapes Cannabis Industry Investment Landscape
Artificial intelligence companies posting explosive gains highlight tech sector rotation that could impact cannabis investment flows and operational efficiency.
Cannabis Edibles Market Eyes Anxiety Treatment Opportunities
Growing consumer interest in cannabis edibles for anxiety management signals potential market expansion as wellness applications gain mainstream acceptance.
Magic Garden Botanicals Wins Cannabis Cups Across NY-NJ Markets
Multi-state operator Magic Garden Botanicals captures awards at MJ Unpacked and High Times Cannabis Cup, signaling brand strength in competitive Northeast corridor.
CRON Drops as Cannabis Sector Faces Broad-Based Selling Pressure
Cronos Group shares decline alongside sector peers as cannabis stocks face headwinds from regulatory uncertainty and market volatility.
SNDL Slides as Cannabis Sector Faces Persistent Headwinds
SNDL Inc shares decline amid broader cannabis sector weakness, highlighting ongoing challenges facing marijuana companies in current market environment.